SCHEMBL6713474

SCHEMBL6713474

Cn1c(C(=O)Nc2ccc(C#N)cc2-c2nnn[nH]2)cc2cccc(OCc3ccco3)c21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.33
ALDH1A1 P00352 4/20 0.33
LMNA P02545 4/20 0.33
KDM4E B2RXH2 3/20 0.33
HSD17B10 Q99714 3/20 0.33
MAPK1 P28482 2/20 0.33
MAPT P10636 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
BDKRB2 P30411 1/20 0.32
TSHR P16473 2/20 0.31
CSF1R P07333 1/20 0.31
KIT P10721 1/20 0.31
KDM1A O60341 1/20 0.31
SCN9A Q15858 1/20 0.31
HPGD P15428 2/20 0.30
MAPK10 P53779 1/20 0.30
POLB P06746 1/20 0.30
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6710050 0.89 TSHR (0.38) RXFP1ALDH1A1LMNAKDM4EHSD17B10
SCHEMBL6710246 0.89 GPR35 (0.34) RXFP1ALDH1A1LMNAKDM4EHSD17B10
SCHEMBL6709131 0.88 PPIA (0.39) RXFP1LMNAMAPTKDM1A
SCHEMBL6708936 0.88 KDM1A (0.34) RXFP1LMNAHSD17B10MAPTSMN1; SMN2
SCHEMBL6707789 0.88 LMNA (0.33) RXFP1LMNAHSD17B10MAPTSMN1; SMN2
SCHEMBL6709981 0.87 LMNA (0.35) RXFP1LMNAHSD17B10MAPTSMN1; SMN2
SCHEMBL6710432 0.87 LMNA (0.35) RXFP1LMNAHSD17B10MAPTSMN1; SMN2
SCHEMBL6707891 0.87 HSD17B10 (0.33) RXFP1ALDH1A1LMNAKDM4EHSD17B10
SCHEMBL6710365 0.85 KDM1A (0.39) RXFP1LMNAMAPTKDM1A
SCHEMBL6710120 0.85 SGMS2 (0.42) LMNAKDM1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 RXFP1 3836/4885ALDH1A1 123/4885LMNA 4062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.